The Affordable Care Act, better known as Obamacare, has 16 days left in public enrollment before the deadline lapses and people are unable to purchase insurance for 2014. With 4.2 million enrolled in the public exchanges, Obamacare has certainly improved from its early showing in December, when website glitches slowed the beginning of the rollout.
The government had originally set 7 million enrollees as the target, but more recently Vice President Joe Biden indicated that 5 or even 6 million enrollees would be a great start for the law, especially given the technical difficulties that have plagued the website. This acknowledgement has been taken by many as a signal that the administration is not confident it can deliver on that original promise. Certainly, the administration has been pulling out all the stops in a last-ditch effort to get as many Americans insured as possible -- including President Obama and Zach Galiafanakis appearing together on a recent internet video that went viral.
Investors need to consider what may happen if Obamacare falls short of its enrollment goal and what this will mean for the various insurers involved in the public exchanges. In this video, health care analysts David Williamson and Michael Douglass discuss the state of play with the law and its implications for health insurers Aetna (NYSE:AET), WellPoint (NYSE:ANTM), and Molina (NYSE:MOH).
Invest In The Next Wave of Health Care Innovation
The Economist compares this disruptive invention to the steam engine and the printing press. Business Insider says it's "the next trillion dollar industry." And the technology behind is poised to set off one of the most remarkable healthcare revolutions in decades. The Motley Fool's exclusive research presentation dives into this technology’s true potential, and it's ability to make life-changing medical solutions never thought possible. To learn how you can invest in this unbelievable new technology, click here now to see our free report.
David Williamson has no position in any stocks mentioned. Michael Douglass has no position in any stocks mentioned. The Motley Fool recommends WellPoint. The Motley Fool owns shares of WellPoint. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.